Italian Patients Journey for Gene Therapy in Haemophilia A
ABSTRACT Introduction Gene therapy (GT) provides sustained FVIII levels without repeated infusions in Hemophilia A (HA) patients thus overcoming a major limitation of replacement therapy. However, issues remain e.g., patient selection criteria, duration and variability of transgene expression, quality of life and long‐term safety.
Giovanni Di Minno +19 more
wiley +1 more source
Posterior Reversible Encephalopathy Syndrome (PRES) Associated With Eclampsia in a Pregnant Adolescent: A Case Report. [PDF]
Gómez KA +2 more
europepmc +1 more source
CAT and TEAM for Longitudinal 360-Degree Assessment in Simulation and Clinical Training. [PDF]
Armijo-Rivera S +5 more
europepmc +1 more source
Integrating Supragingival Scaling and Biofilm Management Into Breast Cancer Patients' Care
ABSTRACT Objective The study was designed as a quasi‐experimental clinical trial to evaluate the impact of chemotherapy on periodontal conditions, haematology and salivary flow in patients with breast cancer and gingivitis, after supragingival scaling.
Kelly R. V. Villafuerte +4 more
wiley +1 more source
Incidence rate and risk factors of ventilator-associated pneumonia in neurocritical patients with acute cerebrovascular diseases: A systematic review and meta-analysis of observational studies. [PDF]
Casallas-Barrera JO +8 more
europepmc +1 more source
Blood Cell Counts and the Duffy Null Phenotype: Beyond Neutropenia
ABSTRACT The absence of Duffy antigen expression on red blood cells, caused by a single nucleotide polymorphism in the DARC/ACKR1 gene, confers protection against malaria and is associated with lower absolute neutrophil counts (ANC) in some studied populations.
Elvira Deolinda R. P. Velloso +11 more
wiley +1 more source
[From ICU to recovery: recurrent pneumonia due to Lophomonas blattarum]. [PDF]
Cárdenas-de Luna MJ +4 more
europepmc +1 more source
[Clinical activity and validation of the disability disc in inflammatory bowel disease]. [PDF]
Plomozo-Román R +7 more
europepmc +1 more source

